Human papilloma virus (HPV) infection can lead to a high risk of cervical cancer . Vaccines notably decrease the occurrence of both preinvasive and invasive forms of cervical cancer. To prove so, a Scotland-based study investigated the impact of age, dosage, and socioeconomic status on the incidence of invasive cervical cancer following bivalent HPV vaccination. Utilizing linked data from screening, immunization, and cancer registries, the study focused on women born between January 1, 1988, and June 5, 1996.
Results revealed no cases of invasive cancer among women immunized at ages 12 or 13, irrespective of dosage. Those vaccinated at ages 14 to 22 with three doses significantly reduced incidence compared to the unvaccinated group. Incidence was higher in more deprived areas, emphasizing the vaccine's greater impact on women from socioeconomically disadvantaged backgrounds. The study…
